Trade Summary

2 days ago, Gloria Melanie, serving as Chief Operating Officer at Immunovant, Inc. (IMVT), sold 3,056 shares at $44.16 per share, for a total transaction value of $134,952.96. Following this transaction, Gloria Melanie now holds 219,301 shares of IMVT.

This sale represents a 1.37% decrease in Gloria Melanie's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, August 20, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:03 PM ET, 1 day after the trade was made.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.